chartexchange

GALT
Galectin Therapeutics Inc.
stockNASDAQ

Market OpenNov 19, 2026 2:57:54 PM EST
2.89USD-3.020%(-0.09)101,373
2.8800Bid3.3000Ask0.4200Spread
Loading…
Loading…
291.02M
Healthcare
Biotechnology
CEO
Harold Shlevin
HQ
Norcross, GA, USA
Previous Close
$2.98
Beta
1.16
52-Week High
$7.13 2025-12-17
52-Week Low
$2.03 2026-05-07
SMA 50
$3.57
SMA 200
$3.21
Avg. Vol 10D
224,395
Avg. Vol 30D
202,844
Avg. Vol 90D
292,557
Relative Vol
0.50
100.88M
46.93M
6.9400%
5,567
Mar 23, 2012 · 1-for-5.9999 (reverse)
GALT Profile

galectin therapeutics (nasdaq: galt) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. drug candidates based on the company's unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. we use naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. using these unique carbohydrate-based candidate compounds that bind and inhibit galectin proteins, we are pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. we focus on diseases with serious, life threatening consequences to patients, and those where current treatment options are limited. our strategy is to establish clinical development approaches that add value to the company in the shortest time possible, and to seek partners as the program advances and requires much

GALT Performance
PeriodPriceDateChangeBeta
1W3.142026-11-12-8.12%0.781
1M3.502026-10-19-17.45%2.764
3M3.672026-08-19-21.39%2.398
6M2.082026-05-19+38.70%1.172
1Y5.742025-11-19-49.74%1.161
2Y2.762024-11-19+4.72%—
5Y2.692021-11-19+7.25%0.806
GALT Stock Summary

Galectin Therapeutics Inc. (NASDAQ:GALT) stock price today is $2.89, and today's volume is 101,065. GALT is down 3.188% today. The 30 day average volume is 202,844. GALT market cap is $291.02M with 100.88M shares outstanding.